Cargando…

Seroprevalence of hepatitis B markers among incarcerated intravenous drug users

BACKGROUND: Drug injection is one of the most prominent risk factors for transmission of viral hepatitis. Prevalence of hepatitis B virus (HBV) is generally higher in prisoners compared with the general population. The object of this study was to assess the markers of HBV and related risk factors am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nokhodian, Zary, Yaran, Majid, Adibi, Peyman, Kassaian, Nazila, Meshkati, Marjan, Ataei, Behrooz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078382/ https://www.ncbi.nlm.nih.gov/pubmed/25002887

Ejemplares similares

Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors
por: Nokhodian, Zary, et al.
Publicado: (2012)

Seroprevalence and Risk Factors of Hepatitis C Virus among Juveniles in Correctional Center in Isfahan, Iran
por: Nokhodian, Zary, et al.
Publicado: (2012)

Seroprevalence of Hepatitis B Infection and Associated Risk Factors among Drug Users in Drop-in Centers of Isfahan, Iran
por: Taleban, Roya, et al.
Publicado: (2018)

Identification of Patients with Hepatitis C Virus Infection in Persons with Background of Intravenous Drug Use: The First Community Announcement-based Study From Iran
por: Nobari, Reza Fadaei, et al.
Publicado: (2012)

Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers
por: Javadi, Abbasali, et al.
Publicado: (2014)

Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners
por: Ataie, Mehdi, et al.
Publicado: (2013)

Seroprevalence of Hepatitis A in Patients with Chronic Hepatitis C in Isfahan Province
por: Shoaei, Parisa, et al.
Publicado: (2012)

The prevalence of isolated hepatitis B core antibody and its related risk factors among male injected drug users in Isfahan prisons
por: Shirani, Kiana, et al.
Publicado: (2015)

Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran
por: Kassaian, Nazila, et al.
Publicado: (2012)

Hepatitis C virus infection in patients with hemophilia in Isfahan, Iran
por: Yazdani, Mohammad Reza, et al.
Publicado: (2012)

Prevalence of Anti HCV Infection in Patients with Beta-Thalassemia in Isfahan-Iran
por: Ataei, Behrooz, et al.
Publicado: (2012)

The assessment of hepatitis B seroprevalence in persons with intravenous drug use history in the Isfahan province: Community-based study
por: Khodadoostan, Mahsa, et al.
Publicado: (2014)

High risky behaviors among intravenous drug users in Isfahan, Iran: A study for hepatitis C harm reduction programs
por: Hassannejad, Razieh, et al.
Publicado: (2012)

Isolation of Hepatitis C Virus in Norjizac Vials
por: Tayeri, Katayoon, et al.
Publicado: (2010)

Surveillance of acute respiratory infections among outpatients: A pilot study in Isfahan city
por: Javadi, Abbasali, et al.
Publicado: (2015)

Prevalence of Hepatitis B Virus Infection in Isfahan Province
por: Nokhodian, Zary, et al.
Publicado: (2014)

Seroprevalence of Hepatitis C Infection among Laboratory Health Care Workers in Isfahan, Iran
por: Shoaei, Parisa, et al.
Publicado: (2012)

Risk Prison and Hepatitis B Virus Infection among Inmates with History of Drug Injection in Isfahan, Iran
por: Dana, Daneshmand, et al.
Publicado: (2013)

Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors
por: Kassaian, Nazila, et al.
Publicado: (2011)

Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases
por: Ataei, Behrooz, et al.
Publicado: (2011)

SARS-CoV-2 Seroprevalence among Health-Care Workers in Isfahan, Iran
por: Rostami, Soodabeh, et al.
Publicado: (2023)

Epidemiology of Bloodstream Infections and Antimicrobial Susceptibility Pattern in ICU and Non-ICU Wards: A Four-Year Retrospective Study in Isfahan, Iran
por: Kassaian, Nazila, et al.
Publicado: (2023)

A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents
por: Nokhodian, Zary, et al.
Publicado: (2022)

Seroprevalence of Bordetella pertussis among a nationally representative sample of Iranian pediatric population: The childhood and adolescence surveillance and prevention of adult noncommunicable disease-V study
por: Nokhodian, Zary, et al.
Publicado: (2021)

Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran
por: Nokhodian, Zary, et al.
Publicado: (2012)

Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors
por: Ataei, Behrooz, et al.
Publicado: (2010)

HIV and other sexually transmitted infections in women with illegal social behavior in Isfahan, Iran
por: Kassaian, Nazila, et al.
Publicado: (2012)

A Process Evaluation of the Isfahan Antibiotic Awareness Campaign: Developing Engagement on Antimicrobial Resistance
por: Rostami, Soodabeh, et al.
Publicado: (2023)

Prevalence of interleukin-28B single nucleotide polymorphism genotypes in patients with hepatitis C infection in Isfahan, Iran
por: Minakari, Mohammad, et al.
Publicado: (2016)

Dermatophytes contamination of wrestling mats in sport centers of Isfahan, Iran
por: Shadzi, Shahla, et al.
Publicado: (2014)

Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study
por: Mostafavi, Sayed Nasser, et al.
Publicado: (2011)

Seroprevalence of hepatitis B virus infection and hepatitis B surface antibody status among laboratory health care workers in Isfahan, Iran
por: Shoaei, Parisa, et al.
Publicado: (2015)

Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study
por: Vakili, Bahareh, et al.
Publicado: (2014)

Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment
por: Nokhodian, Zary, et al.
Publicado: (2020)

Evaluation of Specific IgG Antibody in Subjects Who Had Been Previously Infected with SARS-CoV-2
por: Rostami, Soodabeh, et al.
Publicado: (2023)

Epidemiology of Q fever in Iran: A systematic review and meta-analysis for estimating serological and molecular prevalence
por: Nokhodian, Zary, et al.
Publicado: (2017)

Toxoplasma gondii infection in women of childbearing age of Isfahan, Iran: A population-based study
por: Mostafavi, Nasser, et al.
Publicado: (2012)

Tenofovir in treatment of Iranian patients with chronic hepatitis B virus infection: An open-label case series
por: Ataei, Behrooz, et al.
Publicado: (2016)

Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users
por: Mir-Nasseri, Mohammad Mehdi, et al.
Publicado: (2011)

Intravenous Drug Use and Hepatitis C Virus in Iran
por: Zobeiri, Mehdi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ddnbi48f5igli520siupboq8mn